Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-14T21:54:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T22:04:57.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Data-sharing and study documentation references (e.g., IPD sharing details, CSR, SAP, protocol) have been removed from the page. The core trial information remains, but access to supplementary materials is now limited.
    Difference
    26%
    Check dated 2026-09-23T22:19:41.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0, signaling a page version update. This change reflects a versioned update to the page rather than a modification to study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-09-16T21:00:39.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page's revision metadata was updated, adding new last update dates (2026-08-31, 2027-06-30, 2028-05-31) and a new revision identifier (v3.6.6). The older revision marker (v3.6.5) appears to have been superseded.
    Difference
    0.2%
    Check dated 2026-09-02T19:19:01.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Additional funding information was added to the study record, listing a 2017 U.S. NIH grant/contract. This update clarifies the NIH support behind the trial and its funding source.
    Difference
    0.0%
    Check dated 2026-08-26T21:42:03.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.